Athena Athena

X

Find the latest Drugs in Development and Pipeline Prospector News of Aurigene Pharmaceutical Services.

  • Webinars & Exhibitions

  • Small Molecule Development & Manufacturing

  • Peptide Development & Manufacturing Services

  • Steroid API Manufacturing

  • HPAPI Development Services

PharmaCompass
Aurigene RM
Aurigene Pharmaceutical Services
india-flag Flag
Country
Country
India
Address
Address
39-40 Hosur Road KIADB Industrial Area, Joggers Ln, Phase 2, Electronic City, Bangalore, Karnataka 560100
Telephone
Telephone
+91 7386722272
Contact Info
Others

left grey arrow
right gray arrow
left grey arrow
right gray arrow

Details:

Fermenta Biotech will exclusively license its biocatalytic technology for synthesis of Molnupiravir (Molflu) and supply its enzyme Candida Antarctica B Lipase (CAL B) to Aurigene. Molnupiravir API manufactured by Aurigene will be utilised by Dr Reddy’s for its formulation.


Lead Product(s): Molnupiravir

Therapeutic Area: Infections and Infectious Diseases Product Name: Molflu

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Fermenta Biotech Limited

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Licensing Agreement January 21, 2022

Aurigene company banner

Biotechgate Digital

Not Confirmed

envelop Contact Supplier

Details:

This next-generation adenine nucleotide translocase (ANT) inhibitor, PENAO, was shown to be safe and well-tolerated in a phase I clinical trial conducted in Australia where encouraging efficacy data was observed.


Lead Product(s): PENAO,Sirolimus

Therapeutic Area: Oncology Product Name: PENAO

Highest Development Status: Phase I/ Phase IIProduct Type: Small molecule

Partner/Sponsor/Collaborator: PENAO Pty Ltd

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement August 18, 2021

Aurigene company banner

Biotechgate Digital

Not Confirmed

envelop Contact Supplier

Details:

Through this MOU, the parties will seek to collaborate on efforts to determine market potential for zoliflodacin, therapeutic value to patients and explore possibilities to enter into future manufacturing and supply agreements.


Lead Product(s): Zoliflodacin,Ceftriaxone,Azithromycin

Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed

Highest Development Status: Phase IIIProduct Type: Small molecule

Partner/Sponsor/Collaborator: The Global Antibiotic Research and Development Partnership

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement December 17, 2020

Aurigene company banner

Biotechgate Digital

Not Confirmed

envelop Contact Supplier
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY